Literature DB >> 8198316

Sertraline intoxication in a child.

C A Kaminski1, M S Robbins, R E Weibley.   

Abstract

We describe severe sertraline intoxication in a child after accidental ingestion. Sertraline is a new antidepressant that has potent and selective inhibition of neuronal serotonin reuptake. Drug company-sponsored research has suggested little toxicity for this compound. Our patient exhibited prolonged tachycardia, hypertension, hallucinations, coma, hyperthermia, tremors of all extremities, and skin flushing. Clinicians should consider the possibility of serotonin syndrome among patients with similar clinical features and a recent history of sertraline or other serotonergic agent ingestion.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8198316     DOI: 10.1016/s0196-0644(94)70364-7

Source DB:  PubMed          Journal:  Ann Emerg Med        ISSN: 0196-0644            Impact factor:   5.721


  6 in total

Review 1.  The selective serotonin reuptake inhibitor sertraline: its profile and use in psychiatric disorders.

Authors:  G MacQueen; L Born; M Steiner
Journal:  CNS Drug Rev       Date:  2001

Review 2.  Drug-induced movement disorders.

Authors:  F J Jiménez-Jiménez; P J García-Ruiz; J A Molina
Journal:  Drug Saf       Date:  1997-03       Impact factor: 5.606

3.  Serotonin Syndrome in Children and Adolescents Exposed to Selective Serotonin Reuptake Inhibitors - A Review of Literature.

Authors:  Siqi Xuev; Abel Ickowicz
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2021-08-01

Review 4.  The serotonin syndrome. Implicated drugs, pathophysiology and management.

Authors:  K A Sporer
Journal:  Drug Saf       Date:  1995-08       Impact factor: 5.606

5.  A case of the serotonin syndrome secondary to phenelzine monotherapy at therapeutic dosing.

Authors:  A Malik; N Junglee
Journal:  Case Rep Med       Date:  2015-03-16

6.  Serotonin Syndrome after Clomipramine Overdose in a Child.

Authors:  Meltem Çobanoğulları Direk; Veli Yıldırım; Serkan Güneş; Gülçin Bozlu; Çetin Okuyaz
Journal:  Clin Psychopharmacol Neurosci       Date:  2016-11-30       Impact factor: 2.582

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.